TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2010

Phase I/II study of the Src inhibitor dasatinib in combination with erlotinib in advanced non-small-cell lung cancer.

Eric B Haura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.